Start a conversation ↗Knowledge centre
Selected developments shaping clinical research, bioequivalence and the regulatory environment in Malaysia, ASEAN and beyond.
Latest intelligence
Regional clinical-trial and pharmaceutical developments
MHRA strengthens regulatory partnership with Malaysia to advance healthcare innovation - National Health ExecutiveAsia Pacific Medical Devices Market Size & Analysis, 2034 - Market Data ForecastBMI: Malaysia to see expansion of its clinical research facilities, capabilities - The Edge MalaysiaInitiatives to Establish Capabilities in Early Phase Clinical Research in Malaysia - Applied Clinical TrialsMethods, products and development strategy
Six business lessons from Cipla’s nine-decade journey - Express PharmaComplex Generics: Facts, Figures and Who They Benefit - Teva PharmaceuticalsEMA adopts five product-specific bioequivalence guidelines - Generics and Biosimilars InitiativeImproving the FDA-EMA parallel scientific advice program to advance complex generics - STATGuidance and announcements from medicines regulators
QPS India Successfully Completes Week-Long US FDA Regulatory Inspection - Business WireTechnology influencing trial design and delivery
How AI Is Helping Match Patients to Clinical Trials Faster - PfizerWCG unveils AI-powered solution to accelerate clinical trial kickoffs - Fierce BiotechSuvoda makes Sofia AI assistant available for clinical trials to drive faster answers and action - PR NewswireAI Adoption in Clinical Trials Hindered by Validation, Governance Gaps - The Clinical Trial Vanguard